皇氏集团股份有限公司 关于公司为下属子公司提供担保的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别风险提示： 公司及控股子公司对外担保总额已超过最近一期经审计净资产的 100%，请 投资者注意担保风险。 一、担保情况概述 皇氏集团股份有限公司（以下简称"公司"）分别于 2023 年 5 月 25 日、2023 年 6 月 19 日召开第六届董事会第十九次会议和 2022 年度股东大会，审议通过了 《关于 2023 年度担保额度预计的议案》，根据公司及子公司业务发展、生产经 营等需求，预计 2023 年度公司为子公司（含子公司之间）、子公司为公司提供 担保的额度合计不超过人民币 209,085.67 万元（不含单独经董事会及股东大会审 议通过的担保额度），该担保额度可循环使用，担保有效期为公司 2022 年度股 东大会审议通过之日起的十二个月内，具体内容详见公司于 2023 年 5 月 29 日披 露的《关于 2023 年度担保额度预计的公告》（公告编号：2023-058）。 证券代码：002329 证券简称：皇氏集团 公告编号：2023–084 ...

证券代码：002329 证券简称：皇氏集团 皇氏集团股份有限公司投资者关系活动记录表 编号：2023-03 特定对象调研 □分析师会议 媒体采访 ■业绩说明会 投资者关系活动 □新闻发布会 路演活动 类别 现场参观 其他 | --- | --- | |----------------|----------------------------------------------------------------| | 参与单位名称及 | 皇氏集团 2022 年度业绩说明会采用网络远程方式进行，面向全体投资 | | 人员姓名 | 者 | 时间 2023 年 5 月 18 日 15:00-17:00 地点 价值在线（https://www.ir-online.cn/） 董事长兼总裁 黄嘉棣 副总裁 王鹤飞 公司接待人员 董事兼副总裁、董事会秘书 王婉芳 姓名 独立董事 蒙丽珍 财务负责人 吕德伟 为增进广大投资者对于公司 2022 年度经营情况的了解，公司于 2023 年 5 月 18 日举行了 2022 年度业绩说明会。本次业绩说明会采用 网络远程的方式举行，具体交流内容如下： 1、水牛奶相比普通牛奶有什么优点 ...

证券代码：002329 证券简称：皇氏集团 皇氏集团股份有限公司投资者关系活动记录表 编号：2023-02 □特定对象调研 □分析师会议 □媒体采访 □业绩说明会 投资者关系活动 □新闻发布会 □路演活动 类别 □现场参观 ■其他 中国对外经济贸易信托有限公司厍九睿；工银国际控股有限公司吴亚 雯；嘉实基金管理有限公司岳鹏飞；青岛金光紫金创业投资管理有限 公司雷静；九泰基金管理有限公司杜京果；鸿运私募基金管理（海南） 有限公司舒殷；深圳中天汇富基金管理有限公司许高飞；太平基金管 理有限公司田发祥；上海弢盛资产管理有限公司陈永胜；中银基金杨 参与单位名称及 雷；富敦投资咨询有限公司刘逸飞；元兹投资黄颖峰；中航信托股份 人员姓名 有限公司戴佳敏；德邦基金刘敏；永赢基金黄韵；阳光资产管理股份 有限公司王晓君；上海方物私募基金管理有限公司汪自兵；上海石锋 资产管理有限公司魏翔翔；江苏第五公理投资管理有限公司郭雷雨； 安中投资宋洋；研究所王洁婷；善泽资产胡圳；深圳市中兴威投资管 理有限公司卢晓冬。 时间 2023 年 5 月 12 日 15:00-16:00 地点 以电话会议形式举行"东兴证券——聊一聊水牛奶，皇氏集团公 ...

证券代码：002329 证券简称：皇氏集团 公告编号：2023–050 皇氏集团股份有限公司 关于举办 2022 年度业绩说明会的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 重要内容提示： 皇氏集团股份有限公司（以下简称"公司"）已于 2023 年 04 月 25 日在巨潮 资讯网上披露了《2022 年年度报告全文》及《2022 年年度报告摘要》。为便于广 大投资者更加全面深入地了解公司经营业绩、发展战略等情况，公司定于 2023 年 05 月 18 日（星期四）15:00-17:00 在"价值在线"（www.ir-online.cn）举办皇 1 会议召开时间：2023 年 05 月 18 日（星期四）15:00-17:00 会议召开方式：网络互动方式 会议召开地点：价值在线（www.ir-online.cn） 会 议 问 题 征集 ： 投资 者 可于 2023 年 05 月 18 日前 访 问网 址 https://eseb.cn/14z4hQMtLH2 或使用微信扫描下方小程序码进行会前 提问，公司将通过本次业绩说明会，在信息披露允许范围内就投资 ...

Financial Performance - The company's operating revenue for Q1 2023 was ¥868,810,070.43, representing a year-on-year increase of 53.83% compared to ¥564,794,721.22 in the same period last year[5]. - The net profit attributable to shareholders of the listed company decreased by 93.62% to ¥4,879,611.50 from ¥76,424,672.34 in the previous year[5]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥25,139,929.24, a decrease of 89.06% compared to -¥13,297,493.89 in the same period last year[5]. - The basic and diluted earnings per share decreased by 93.64% to ¥0.0058 from ¥0.0912 in the same period last year[5]. - Net profit for Q1 2023 was ¥4,547,796.39, a significant decrease from ¥75,958,732.29 in Q1 2022[21]. - The total comprehensive income attributable to the parent company is CNY 76,425,063.40, up from CNY 4,384,816.04 year-over-year[22]. Cash Flow and Liquidity - The net cash flow from operating activities increased by 4,021.81% to ¥113,246,715.68 from -¥2,887,611.37 in the previous year[5]. - Operating cash inflow for Q1 2023 is CNY 903,534,038.02, compared to CNY 679,420,994.23 in the previous year, reflecting a growth of approximately 33%[24]. - The net cash flow from operating activities is CNY 113,246,715.68, a turnaround from a net outflow of CNY -2,887,611.37 in the same quarter last year[24]. - The net cash flow from investing activities is CNY -74,631,834.65, an improvement from CNY -180,666,147.67 in the previous year[25]. - Cash inflow from financing activities totals CNY 456,484,625.62, down from CNY 907,183,332.78 in the previous year[25]. - The company’s cash and cash equivalents increased to ¥759,142,509.39 from ¥545,950,835.01, reflecting a growth of 38.9%[16]. Assets and Liabilities - The total assets at the end of the reporting period were ¥6,273,212,837.91, an increase of 6.43% from ¥5,894,253,597.57 at the end of the previous year[6]. - Total assets as of the end of Q1 2023 amounted to ¥6,273,212,837.91, compared to ¥5,894,253,597.57 at the beginning of the year, reflecting a growth of 6.4%[19]. - Total liabilities increased to ¥4,323,114,889.43 in Q1 2023, up from ¥3,957,783,187.65 at the start of the year, marking a rise of 9.2%[19]. - Current assets totaled ¥2,588,597,173.43 at the end of Q1 2023, compared to ¥2,246,462,575.12 at the beginning of the year, indicating a growth of 15.2%[18]. - The company reported a decrease in accounts receivable to ¥646,569,676.78 from ¥502,513,347.87, representing a 28.7% increase year-over-year[17]. Shareholder Equity - The equity attributable to shareholders of the listed company was ¥1,559,227,546.09, a slight increase of 0.89% from ¥1,545,532,049.01 at the end of the previous year[6]. - The company’s equity attributable to shareholders rose to ¥1,559,227,546.09 from ¥1,545,532,049.01, a slight increase of 0.9%[19]. Operating Costs and Revenue Drivers - Total operating costs for Q1 2023 were ¥892,358,663.26, up 46.4% from ¥609,573,719.48 in Q1 2022[21]. - The increase in operating revenue was primarily driven by increased sales of photovoltaic modules and EPC business income[9]. Research and Development - Research and development expenses for Q1 2023 were ¥10,418,801.61, down from ¥18,111,358.47 in the previous year, a decrease of 42.5%[21]. Stock and Incentives - The company completed the first grant of the 2022 restricted stock incentive plan, increasing the total share capital from 837,640,035 shares to 869,099,335 shares[14].

Financial Performance - The company's operating revenue for 2022 was ¥2,890,700,549.88, representing a 12.54% increase compared to ¥2,568,690,730.34 in 2021[22] - The net profit attributable to shareholders for 2022 was ¥12,023,464.10, a significant turnaround from a loss of ¥471,871,670.86 in 2021, marking a 102.55% improvement[22] - Basic earnings per share for 2022 were ¥0.0144, compared to a loss of ¥0.5633 per share in 2021, reflecting a 102.56% increase[22] - The company reported a significant reduction in net profit after deducting non-recurring gains and losses, with a loss of ¥106,441,359.94 in 2022, an improvement of 79.54% from the previous year's loss of ¥520,162,275.60[22] - The company's total revenue for Q4 2022 was ¥834,465,922.69, showing a significant increase compared to Q1 2022's revenue of ¥564,794,721.22[27] - The net profit attributable to shareholders for Q3 2022 was -¥38,323,267.31, and for Q4 2022, it further declined to -¥45,624,562.42, indicating a downward trend in profitability[27] - The company reported non-recurring gains of ¥118,464,824.04 in 2022, significantly higher than the previous year's non-recurring gains of ¥48,290,604.74[30] - The company reported a total revenue of 1.5 billion RMB for the fiscal year 2022, representing a year-over-year increase of 10%[167] - The company reported a significant increase in revenue, achieving a total of 1.5 billion yuan in 2022, representing a year-over-year growth of 20%[171] Cash Flow and Assets - The net cash flow from operating activities decreased by 86.19% to ¥36,769,019.05 in 2022, down from ¥266,229,464.68 in 2021[22] - The net cash flow from financing activities surged by 242.03% to ¥393,074,290.57, attributed to cash received from the transfer of 20% equity in subsidiaries[111] - Cash and cash equivalents decreased to CNY 545.95 million, representing 9.26% of total assets, down by 3.79 percentage points[117] - Accounts receivable increased to CNY 502.51 million, accounting for 8.53% of total assets, up by 0.67 percentage points[117] - Inventory rose to CNY 471.21 million, making up 7.99% of total assets, an increase of 0.87 percentage points[117] - Fixed assets increased to CNY 1.57 billion, representing 26.63% of total assets, up by 6.62 percentage points, primarily due to the construction of new production facilities[117] Market and Product Development - The overall market for dairy products in China is expanding, driven by increasing consumer health awareness and innovative sales channels such as online shopping and live streaming[33] - The company has successfully introduced and transformed water buffalo embryo breeding technology, significantly reducing the breeding cycle from 12 years to 3-4 years, with an expected increase in milk yield by over 300% per head[35] - The company launched several new products, including the "浓醇" series, and has seen strong performance from core products like water buffalo milk and various yogurt lines[69] - The company is actively expanding into the photovoltaic industry, with projects totaling 5GW approved, including collaborations with major state-owned enterprises[74] - The company is focusing on expanding its market presence in core regions and enhancing sales in the eastern and Chengdu-Chongqing areas[132] - New product launches are expected to contribute an additional 300 million RMB in revenue, with a focus on dairy and health products[167] Research and Development - The company is developing a water buffalo estrus detection system to enhance production efficiency and economic benefits[100] - The company is working on the IVEP technology for water buffalo to optimize embryo production processes[100] - The company is conducting research on serum-free water buffalo embryo culture medium to improve embryo production efficiency and reduce costs[102] - The company's R&D investment increased by 20.58% to ¥83,945,052.19 in 2022, representing 2.90% of operating revenue, up from 2.71% in 2021[107] - The company is investing heavily in R&D, with a budget of 300 million yuan allocated for new technology development in the upcoming year[171] Governance and Management - The company is committed to enhancing its governance structure and internal control systems in compliance with relevant regulations[149] - The company has established a robust investor relations management system to improve communication with stakeholders[149] - The company maintained an independent asset structure, ensuring complete operational autonomy[150] - The human resources department operates independently, managing recruitment, training, and compensation without influence from the controlling shareholder[151] - The financial department is fully independent, with its own bank accounts and tax obligations, adhering to legal accounting standards[152] Strategic Initiatives - The company aims to achieve double-digit revenue growth in the dairy sector while implementing targeted measures to increase revenue and profitability[136] - The company plans to enhance its digital transformation across the entire supply chain, including automated and intelligent upgrades in production lines[133] - The company is considering strategic acquisitions to enhance its supply chain capabilities, with a budget of 500 million RMB allocated for potential deals[167] - The company is focusing on capital operations and internal control improvements as part of its strategic development[187] Risks and Challenges - The management discussion indicates potential risks and outlines the operational plan for 2023, emphasizing the need for investor caution[5] - The company acknowledges potential risks in food safety due to the complexity of the dairy production chain and has implemented a robust quality management system to mitigate these risks[140] - Fluctuations in raw material prices, such as milk and packaging materials, could impact profit margins, prompting the company to adopt refined management practices to control costs[143]